Liu T - Search Results

1

Prognostic Value of Immunoscore and PD-L1 Expression in Metastatic Colorectal Cancer Patients with Different RAS Status after Palliative Operation.

Liu R, Peng K, Yu Y, Liang L, Xu X, Li W, Yu S, Liu T. Liu R, et al. Among authors: liu t. Biomed Res Int. 2018 Jan 31;2018:5920608. doi: 10.1155/2018/5920608. eCollection 2018. Biomed Res Int. 2018. PMID: 29662888 Free PMC article.

2

Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor.

Cui Y, Li Q, Yu Y, Chen Y, Feng Y, Wang Y, Liu T. Cui Y, et al. Among authors: liu t. Cancer Chemother Pharmacol. 2013 Jan;71(1):145-52. doi: 10.1007/s00280-012-1991-y. Epub 2012 Oct 12. Cancer Chemother Pharmacol. 2013. PMID: 23064955 Clinical Trial.

3

C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis.

Yu S, Yu Y, Zhao N, Cui J, Li W, Liu T. Yu S, et al. Among authors: liu t. PLoS One. 2013 Nov 4;8(11):e79137. doi: 10.1371/journal.pone.0079137. eCollection 2013. PLoS One. 2013. PMID: 24223894 Free PMC article. Review.

4

[Influence of 17AAG on proliferation and invasion of gastric cancer cell and its mechanism].

Cui Y, Yu Y, Liu T, Xie Q, Wu W, Liu K. Cui Y, et al. Among authors: liu k, liu t. Zhonghua Wei Chang Wai Ke Za Zhi. 2014 Oct;17(10):1031-5. Zhonghua Wei Chang Wai Ke Za Zhi. 2014. PMID: 25341914 Chinese.

5

Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients.

Li W, Xu J, Shen L, Liu T, Guo W, Zhang W, Chen Z, Zhu X, Li J. Li W, et al. Among authors: liu t. BMC Cancer. 2014 Dec 19;14:986. doi: 10.1186/1471-2407-14-986. BMC Cancer. 2014. PMID: 25527007 Free PMC article. Clinical Trial.

6

Low percentage of CD24hiCD27⁺CD19⁺ B cells decelerates gastric cancer progression in XELOX-treated patients.

Yang J, Li W, Luo F, Zhao N, Zhang W, Zhang D, Qian J, Yu Y, Zheng X, Wang Y, Feng Y, Liu T, Chu Y. Yang J, et al. Among authors: liu t. Int Immunopharmacol. 2015 Jun;26(2):322-7. doi: 10.1016/j.intimp.2015.04.011. Epub 2015 Apr 18. Int Immunopharmacol. 2015. PMID: 25899086

7

Activation of FOXO3a suggests good prognosis of patients with radically resected gastric cancer.

Yu S, Yu Y, Sun Y, Wang X, Luo R, Zhao N, Zhang W, Li Q, Cui Y, Wang Y, Li W, Liu T. Yu S, et al. Among authors: liu t. Int J Clin Exp Pathol. 2015 Mar 1;8(3):2963-70. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26045805 Free PMC article.

8

Prognostic factors in patients with recurrent or metastatic retroperitoneal leiomyosarcoma.

Li Q, Zhuang R, Zhu J, Lu W, Hou Y, Liu J, Zhang Y, Wang Y, Liu T, Wang Z, Zhou Y. Li Q, et al. Among authors: liu j, liu t. Future Oncol. 2015;11(12):1759-66. doi: 10.2217/fon.15.54. Future Oncol. 2015. PMID: 26075444

9

Low-dosed docetaxel showed equivalent efficacy but improved tolerability compared with oxaliplatin in the S-1-based first-line chemotherapy regimen for metastatic or recurrent gastric adenocarcinoma.

Guo M, Yu Y, Wang Y, Cui Y, Li Q, Feng Y, Li W, Zhuang R, Liu T. Guo M, et al. Among authors: liu t. Med Oncol. 2015 Sep;32(9):230. doi: 10.1007/s12032-015-0675-y. Epub 2015 Aug 13. Med Oncol. 2015. PMID: 26268397 Clinical Trial.

10

Asparaginyl endopeptidase promotes the invasion and metastasis of gastric cancer through modulating epithelial-to-mesenchymal transition and analysis of their phosphorylation signaling pathways.

Cui Y, Wang Y, Li H, Li Q, Yu Y, Xu X, Xu B, Liu T. Cui Y, et al. Among authors: liu t. Oncotarget. 2016 Jun 7;7(23):34356-70. doi: 10.18632/oncotarget.8879. Oncotarget. 2016. PMID: 27102302 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36,182 results

Search Page

Filters